The tracker lists key scientific information about the different vaccine candidates including immunogenicity, manufacturing, and stability factors. The information listed in the interactive charts includes development platform or targeted proteins, vaccine delivery system, and delivery route.

New Vaccine Mapper tracks the progress of coronavirus vaccine candidates. Image courtesy of University of Notre Dame Center for Research Computing.

The Vaccine Mapper uses public information on coronavirus vaccines pulled from resources including the World Health Organization, the Milken Institute, and the global coronavirus cases map from Johns Hopkins University.

MilliporeSigma, Baylor partnering on COVID-19 vaccine
MilliporeSigma and Baylor College of Medicine have announced they are working to advance a vaccine manufacturing platform to fight COVID-19. The partnership...

Need for efficiency, COVID-19 vaccine spurs biomanufacturing in 2020
With the urgent need for COVID-19 therapies and vaccines, funding agencies have prioritized biomanufacturing; companies in turn are preparing to ramp...

Merck to acquire Themis for SARS-CoV-2 vaccine
Merck announced on May 26 that it has entered an agreement to acquire privately held Themis, a company that is developing a vaccine candidate for SARS-CoV-2.

Sinovac receives $15M for COVID-19 vaccine
Biopharmaceutical company Sinovac Biotech announced that Advantech Capital and Vivo Capital invested $15 million in the firm's research and development...

IAVI, Merck partner on SARS-CoV-2 vaccine
Merck and IAVI, a nonprofit scientific research organization, announced that they are partnering to develop a recombinant vesicular stomatitis virus vaccine...